Abbott India

ABBOTINDIA.NSPre-clinical

Mumbai, IndiaFounded 1944abbott.co.in

Abbott India operates as a publicly traded subsidiary of Abbott Laboratories, focusing on bringing innovative healthcare solutions to the Indian market. The company has established a strong presence across multiple therapeutic areas including cardiology, diabetes care, women's health, and nutrition. With manufacturing facilities and a robust distribution network across India, Abbott India plays a crucial role in making quality healthcare accessible to diverse patient populations throughout the subcontinent.

Market Cap

$6.1B

Founded

1944

Employees

5,000-10,000

Focus

Biotech

ABBOTINDIA.NS · Stock Price

USD 26750.00+9334.70 (+53.60%)

Historical price data

AI Company Overview

Technology Platform

Diversified healthcare platform combining pharmaceuticals, medical devices, diagnostics, and nutrition products with focus on addressing India-specific healthcare needs.

Funding History

IPOUndisclosedUndisclosedJun 15, 2002

Opportunities

Significant growth potential driven by India's large population, expanding middle class, increasing healthcare awareness, and government healthcare initiatives.

Digital health integration and rural market penetration present substantial opportunities.

Risk Factors

Regulatory pricing pressures, intense generic competition, currency fluctuations, and supply chain complexities pose ongoing challenges.

Market access in rural areas and healthcare infrastructure limitations remain key risks.

Competitive Landscape

Competes with both global pharmaceutical giants like Pfizer and Novartis, as well as strong domestic players like Sun Pharma and Dr. Reddy's. Differentiates through diversified portfolio, strong brands, and comprehensive market coverage across pharmaceuticals, devices, and nutrition.

Publications